Rugby Polyvinyl Alcohol 1.4% Lubricating Eye Drops

Polyvinyl Alcohol is a synthetic polymer used primarily as an ophthalmic lubricant and viscosity-increasing agent to treat dry eye symptoms and stabilize the tear film. It belongs to the class of ocular lubricants.

For the treatment of dry eye symptoms, the standard adult dosage of Polyvinyl Alcohol 1.4% or 3.0% ophthalmic solution is as follows:

• Standard Dosing: Instill 1 to 2 drops in the affected eye(s) as needed.
• Frequency: Most patients find relief with 3 to 4 applications per day. However, depending on the severity of the dryness and environmental factors (such as air conditioning or prolonged screen use), it may be used more frequently.
• Chronic Conditions: For severe keratoconjunctivitis sicca, a healthcare provider may recommend use every 1 to 2 hours.

Polyvinyl Alcohol is generally considered safe for pediatric use when used under the guidance of a healthcare professional.

• Children (All Ages): The dosage is typically the same as the adult dosage (1-2 drops as needed). However, parents should consult a pediatrician or pediatric ophthalmologist before starting treatment to rule out underlying infections or structural issues with the tear ducts.

Renal Impairment

No dosage adjustments are required for patients with renal impairment. Due to the lack of systemic absorption, Polyvinyl Alcohol does not place a burden on the kidneys.

Hepatic Impairment

No dosage adjustments are required for patients with hepatic impairment. The drug is not metabolized by the liver.

Elderly Patients

No specific dosage adjustments are necessary for geriatric patients. In fact, elderly patients often require more frequent dosing due to age-related atrophy of the lacrimal glands (the glands that produce tears).

Proper administration is crucial to ensure efficacy and prevent contamination. Follow these steps:

1. 1Wash Hands: Always wash your hands thoroughly with soap and water before touching your eyes or the medication bottle.
2. 2Check the Tip: Ensure the dropper tip is not chipped or cracked. Do not let the tip touch your eye, eyelid, fingers, or any other surface to avoid bacterial contamination.
3. 3The Technique: Tilt your head back and pull down your lower eyelid to create a small pocket. Hold the dropper upside down near the eye. Look up and away from the dropper and squeeze out a drop.
4. 4Punctal Occlusion: After instilling the drop, close your eye and gently press your finger against the inner corner of the eye (near the nose) for 1 to 2 minutes. This prevents the medication from draining into the tear duct and keeps it on the eye surface longer.
5. 5Wait Between Meds: If you are using other eye medications, wait at least 5 to 10 minutes before applying the next product.
6. 6Storage: Store at room temperature (15°C to 30°C or 59°F to 86°F). Keep the bottle tightly closed when not in use.

Since Polyvinyl Alcohol is typically used 'as needed,' missing a dose is not clinically significant. If you are on a scheduled regimen and miss a dose, apply it as soon as you remember. If it is almost time for your next dose, skip the missed one and resume your regular schedule. Do not 'double up' on drops.

An overdose of Polyvinyl Alcohol eye drops is highly unlikely to cause systemic toxicity.

• Symptoms: Excessive use may lead to temporary blurred vision or a sticky sensation on the eyelids.
• Accidental Ingestion: If the solution is accidentally swallowed, it is generally non-toxic in small amounts. However, you should contact a Poison Control Center or seek emergency medical attention if a large quantity is consumed, especially by a child, as the preservatives in the solution could cause gastrointestinal upset.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or frequency without medical guidance, especially if your symptoms persist for more than 72 hours.

Polyvinyl Alcohol is exceptionally well-tolerated, but because it is applied directly to the sensitive tissues of the eye, some localized reactions are common. These typically occur immediately after application and are transient.

• Transient Stinging or Burning: A mild, brief stinging sensation is the most frequently reported side effect. This occurs as the pH of the drop equilibrates with the pH of your natural tears.
• Blurred Vision: Because PVA increases the viscosity of the tear film, your vision may become slightly 'thick' or blurry for 1 to 3 minutes after instillation. Patients should wait for their vision to clear before driving or operating machinery.
• Eyelid Matting or Crusting: As the water in the solution evaporates, the polymer can leave a thin, clear residue on the eyelashes or the corners of the eyelids, which may feel sticky or 'crusty.'

Polyvinyl Alcohol is intended for topical ophthalmic use only. It must not be injected or ingested. To ensure the safety of the product, the container must be kept sterile. If the solution changes color or becomes cloudy, it should be discarded immediately. Patients should also be aware that artificial tears like PVA treat the symptoms of dry eye but may not address the underlying cause (such as autoimmune disease or meibomian gland dysfunction).

No FDA black box warnings for Polyvinyl Alcohol.

• Contamination Risk: The most significant risk associated with Polyvinyl Alcohol use is bacterial keratitis (infection of the cornea) caused by a contaminated dropper tip. Once the tip touches a surface, it can introduce bacteria into the bottle, which then multiply and are instilled into the eye.

There are no known drugs that must never be used with Polyvinyl Alcohol due to systemic chemical reactions. However, from a physical and pharmaceutical perspective, PVA should not be mixed directly in the same bottle with other eye drops, as this can alter the pH and stability of both medications.

While systemic interactions are absent, topical interactions can occur:

• Other Ophthalmic Viscosity Agents: Using Polyvinyl Alcohol simultaneously with other thickeners (like Hydroxypropyl Methylcellulose) may cause excessive blurring and a buildup of residue on the eyelids.
• Medicated Eye Drops (e.g., Antibiotics, Steroids): Polyvinyl Alcohol can theoretically increase the 'residence time' of other medications on the eye. While often beneficial, it can also increase the risk of side effects from those medications (such as steroid-induced pressure spikes). Always follow the '5-minute rule' (wait 5 minutes between different drops).

Polyvinyl Alcohol is contraindicated in the following scenarios:

• Hypersensitivity: Any patient with a known allergy to Polyvinyl Alcohol or any of the inactive ingredients (such as the preservatives Benzalkonium Chloride, Disodium EDTA, or Thimerosal) must not use the product. An allergic reaction could lead to severe conjunctival edema or dermatitis of the eyelids.
• Active Ocular Infection (Untreated): While not strictly contraindicated, PVA should not be used as a substitute for anti-infective treatment in the presence of bacterial, viral, or fungal conjunctivitis. Using a lubricant in an infected eye without proper antimicrobial coverage can sometimes spread the pathogen or mask worsening symptoms.

Conditions requiring careful risk-benefit analysis include:

FDA Pregnancy Category: Not Formally Assigned (Typically treated as Category C)

Polyvinyl Alcohol is generally considered safe for use during pregnancy. Because it is not absorbed systemically, there is no measurable exposure to the developing fetus. There are no known reports of teratogenicity (birth defects) associated with the topical use of PVA. However, as with all medications, pregnant women should consult their obstetrician before use. It is not used in fertility treatments and has no known impact on conception.

It is highly unlikely that Polyvinyl Alcohol is excreted in human breast milk in any detectable quantity, given the lack of systemic absorption from the eye. There are no known adverse effects on the nursing infant. The benefits of treating maternal dry eye symptoms usually far outweigh any theoretical, negligible risk to the infant.

Polyvinyl Alcohol is approved for use in children. It is frequently used to treat dry eyes associated with pediatric conditions like juvenile idiopathic arthritis or environmental allergies. Parents should be instructed on proper administration to avoid the child blinking the drop out immediately. It is important to ensure that the child's 'dry eye' is not actually an undiagnosed infection or an allergy that requires antihistamines.

Polyvinyl Alcohol (PVA) is a non-ionic surfactant and polymer. Its molecular mechanism involves the stabilization of the precorneal tear film. PVA has a high affinity for water and forms a hydrogel-like layer over the cornea. Specifically, it increases the viscosity of the aqueous layer, which reduces the 'break-up time' (BUT) of the tears. By mimicking the mucin components of the tear film, PVA allows the aqueous layer to spread more evenly across the hydrophobic corneal epithelium, providing a smooth optical surface and protecting the delicate epithelial cells from desiccation (drying out).

• Onset of Action: Immediate symptomatic relief upon instillation.
• Duration of Effect: Typically 15 to 45 minutes, depending on the concentration and the severity of the patient's tear deficiency.
• Tolerance: There is no evidence that the eye develops a 'tolerance' to PVA; it remains effective over years of use. However, the underlying dry eye disease may progress, requiring more frequent application.